Creative Medical Technology

Penny Stocks Biotech Stocks Healthcare Stocks

$1.93

+0.15 (+8.43%)

As of Feb 8, 2:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,630.1% upside

Low Target $22.85

Average Target $33.39

High Target $43.53

Current Price $1.93

Current
$1.93

Target
$33.39

$22.85 $33.39 avg $43.53

Scenario Analysis

Bear Case

$22.85

1,083.9%

Low target

Base Case

$33.39

+1,630.1%

Avg target

Bull Case

$43.53

+2,155.4%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$29.76

-93.5% from high

52-Week Low

$17.39

+-88.9% from low

Target vs 52W High

$33.39

+12.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%